Motion-sickness medications for aircrew: impact on psychomotor performance
- PMID: 15945400
Motion-sickness medications for aircrew: impact on psychomotor performance
Abstract
Introduction: Motion sickness remains a significant problem for aircrew both in the flying environment (airsickness) and for aircrew deployed at sea (seasickness). While some anti-motion-sickness medications provide reasonable efficacy, adverse neurocognitive effects limit their use in military personnel engaged in safety-sensitive operational roles such as flying. The purpose of this study was to assess the impact on psychomotor performance of promethazine, meclizine, and dimenhydrinate and to determine if the addition of pseudoephedrine or damphetamine to promethazine would ameliorate its adverse effects.
Methods: There were 21 subjects (11 men, 10 women), aged 22-59, who were assessed for psychomotor performance on 4 tasks as well as with sleepiness and drug side-effects questionnaires. Psychomotor testing was conducted prior to, and for 7 h after, ingestion of a single dose of each of placebo, promethazine 25 mg, meclizine 50 mg, dimenhydrinate 50 mg, promethazine 25 mg plus pseudoephedrine 60 mg, and promethazine 25 mg plus d-amphetamine 10 mg.
Results: Relative to placebo, promethazine, meclizine, and promethazine plus pseudoephedrine impaired performance on all four tasks [serial reaction time (SRT), logical reasoning (LRT), serial subraction (SST), and multitask (MT)]. Dimenhydrinate impaired performance on the SRT only. Promethazine plus d-amphetamine did not impair performance on any task nor did it result in increased sleepiness. The times to recovery of normal performance for SRT with promethazine, meclizine, dimenhydrinate, and promethazine plus pseudoephedrine were > 7.25, 7.25, 4.25, and 7.25 h, respectively; for LRT were > 7.25, > 7.25, ns, and 7.25 h; for SST were > 7.25, > 7.25, ns, and 7.25 h; for MT were 7.25, 7.25, ns, and 7.25 h. Recovery times to baseline sleepiness levels for promethazine, meclizine, dimenhydrinate, and promethazine plus pseudoephedrine were 7.25, > 7.25, 6.25, and > 7.25 h.
Conclusion: Only promethazine plus d-amphetamine was free from impact on psychomotor performance and did not increase sleepiness.
Similar articles
-
Evaluation of antimotion sickness drug side effects on performance.Aviat Space Environ Med. 1985 Apr;56(4):310-6. Aviat Space Environ Med. 1985. PMID: 3888169 Clinical Trial.
-
Effects of some motion sickness suppressants on static and dynamic tracking performance.Aviat Space Environ Med. 1985 Apr;56(4):344-50. Aviat Space Environ Med. 1985. PMID: 3994616 Clinical Trial.
-
Melatonin and zopiclone as pharmacologic aids to facilitate crew rest.Aviat Space Environ Med. 2001 Nov;72(11):974-84. Aviat Space Environ Med. 2001. PMID: 11718517 Clinical Trial.
-
Psychophysiological aspects of motion sickness.Percept Mot Skills. 1997 Dec;85(3 Pt 2):1163-7. doi: 10.2466/pms.1997.85.3f.1163. Percept Mot Skills. 1997. PMID: 9450266 Review.
-
Expanded table: some drugs for altitude illness, jet lag, and motion sickness.Med Lett Drugs Ther. 2019 Oct 7;61(1582):e161-e163. Med Lett Drugs Ther. 2019. PMID: 31599874 Review. No abstract available.
Cited by
-
The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy.J Hepatol. 2020 Apr;72(4):746-760. doi: 10.1016/j.jhep.2019.11.007. Epub 2019 Nov 22. J Hepatol. 2020. PMID: 31760071 Free PMC article.
-
Motion sickness: an overview.Drugs Context. 2019 Dec 13;8:2019-9-4. doi: 10.7573/dic.2019-9-4. eCollection 2019. Drugs Context. 2019. PMID: 32158479 Free PMC article. Review.
-
The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness.CNS Neurosci Ther. 2016 Aug;22(8):715-22. doi: 10.1111/cns.12566. Epub 2016 May 9. CNS Neurosci Ther. 2016. PMID: 27160425 Free PMC article.
-
Neuropharmacology of vestibular system disorders.Curr Neuropharmacol. 2010 Mar;8(1):26-40. doi: 10.2174/157015910790909511. Curr Neuropharmacol. 2010. PMID: 20808544 Free PMC article.
-
Investigation of the usefulness of zaleplon at two doses to induce afternoon-sleep under noise interference and its effects on psychomotor performance and vestibular function.Mil Med Res. 2016 Mar 1;3:5. doi: 10.1186/s40779-016-0075-4. eCollection 2016. Mil Med Res. 2016. PMID: 26937286 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous